Isracann Biosciences Inc.
ISCNF
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.73M | 1.90M | 2.30M | 3.35M | 3.47M |
| Depreciation & Amortization | 32.80K | 33.10K | 34.60K | 34.00K | 33.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.76M | 1.93M | 2.33M | 3.39M | 3.51M |
| Operating Income | -1.76M | -1.93M | -2.33M | -3.39M | -3.51M |
| Income Before Tax | -3.58M | -3.71M | -19.20M | -20.02M | -20.34M |
| Income Tax Expenses | -- | -- | 25.00K | 25.00K | 25.00K |
| Earnings from Continuing Operations | -3.58 | -3.71 | -19.23 | -20.04 | -20.37 |
| Earnings from Discontinued Operations | -- | -- | 0.00 | 0.00 | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.58M | -3.71M | -19.23M | -20.04M | -20.37M |
| EBIT | -1.76M | -1.93M | -2.33M | -3.39M | -3.51M |
| EBITDA | -1.73M | -1.90M | -2.30M | -3.35M | -3.47M |
| EPS Basic | -0.02 | -0.02 | -0.13 | -0.14 | -0.14 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.02 | -0.02 | -0.13 | -0.14 | -0.14 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 603.39M | 591.01M | 583.91M | 573.81M | 562.89M |
| Average Diluted Shares Outstanding | 603.39M | 591.01M | 583.91M | 573.81M | 562.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |